AIK-2

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAIK-2
Drug Alias NameAIK-2aAIK-2cJNK allosteric inhibitor (Allinky)MAP kinase inhibitors (Allinky)AIK-2 +[6] 
ClassificationSmall molecules
Mechanisms of Actionc-Jun N-terminal kinase inhibitorsNeuroprotectants
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsAlzheimer DiseaseStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllinky Biopharma SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllinky Biopharma SL
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseStroke

Other Information

ATC CodeN/A
Related LinksN/A